UK MULTI-CENTRE TRIAL IN ATHEROSCLEROTIC RENOVASCULAR DISEASE ASTRAL A ngioplasty and ST ent for R enal A rtery L esions. Philip A Kalra Lead Nephrologist for ASTRAL, Hope Hospital, Salford, UK, On behalf of the ASTRAL TMC and collaborators. ASTRAL Trial Schema.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Philip A Kalra
Lead Nephrologist for ASTRAL, Hope Hospital, Salford, UK,
On behalf of the ASTRAL TMC and collaborators
No revascularisationMedical Treatment only
with angioplasty and/or stent
(and medical treatment)
Diagnosis of ARVD (Unilateral or Bilateral)Revascularisation not contraindicated
Uncertain whether to revasculariseRandomisation
Negative change = Improvement in SCr (i.e. reduction in SCr)
HR=0.90, 95% CI=0.66 to 1.15
HR=0.92, 95% CI=0.68 to 1.26